Shoulder Adhesive Capsulitis ; Comparison Between Three Theraputic Approaches
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Sohag University
- Enrollment
- 54
- Locations
- 1
- Primary Endpoint
- Improvement in range of motion of shoulder joint
Study Overview
Brief Summary
This study will compare between the effect of three treatment modalities of shoulder adhesive capsulitis to hilight the best technique to improve pain and range of motion outcome measures .
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Triple (Participant, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 16 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •gross limitation of passive shoulder movement
- •pain interfering with daily activities
- •painful restiction of active and passive movement of shoulder
Exclusion Criteria
- •presence of degenerative pathology
- •contraindication to steroid injection
- •deformity affecting upper limb
- •history of previous shoulder injection in the past 4 weeks
Arms & Interventions
Suprascapular nerve block
This group will include will under go suprascapularnerve block as following :10 ml of .5% bupivacaine and 2 ml of methylpradnisolon 40mg/ml
Intervention: Local injection of shoulder joint (Procedure)
Hydrodilatation of shoulder capsule
This group will undergo intraarticular hydrodilatation by injection of :first lidocaine10ml%followed by 1ml of methylprednisolon 40mg/ml and finally 20ml of .9 % sodium chloride slowly in the gleno humeral joint
Intervention: Local injection of shoulder joint (Procedure)
Hydrodilatation of shoulder interval
This group will undergo interval hydrodilatation by injection of :first mepivacaine 10ml folowed by 20ml of sterile water slowly in the shoulder interval
Intervention: Local injection of shoulder joint (Procedure)
Outcomes
Primary Outcomes
Improvement in range of motion of shoulder joint
Time Frame: 12 weeks efter intervention
Improvement will be measured by measuring active and passive range of motion
Improvement in pain
Time Frame: 12 weeks after intervention
Improvement will be measured by VAS ( visual auditory assessment )
Secondary Outcomes
No secondary outcomes reported
Investigators
Shorouk Ayman Mohamed
Resident doctor
Sohag University